Literature DB >> 16371295

Self-injection of monthly combined hormonal contraceptive.

Nancy L Stanwood1, Kara Eastwood, Alison Carletta.   

Abstract

OBJECTIVES: The monthly injectable contraceptive is usually administered in the office. We aimed to compare home self-injection with office administration with respect to satisfaction, compliance, and time and money spent on contraceptive behavior.
METHODS: We enrolled 16 subjects and taught them self-injection for a prospective cohort trial with crossover. Subjects performed three self-injections at home and then had three office injections by the nurse.
RESULTS: Ten subjects completed the protocol. They reported similarly low pain and anxiety with nurse injections and self-injections. Women reported spending less money and similar time for home injections. Most subjects strongly preferred giving themselves injections at home to office injections and would recommend self-injection to other women.
CONCLUSIONS: Self-injection of the monthly contraceptive at home is a preferable alternative to office administration for these subjects. This study demonstrates the feasibility of teaching women self-injection. Future studies should look at how best to teach women self-injection and to select women who will be successful with self-injection of contraceptives.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371295     DOI: 10.1016/j.contraception.2005.05.020

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  8 in total

1.  Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate.

Authors:  Anitra Beasley; Katharine O'Connell White; Serge Cremers; Carolyn Westhoff
Journal:  Contraception       Date:  2014-02-07       Impact factor: 3.375

2.  Self-administration of subcutaneous depot medroxyprogesterone acetate by adolescent women.

Authors:  Rebekah L Williams; Devon J Hensel; J Dennis Fortenberry
Journal:  Contraception       Date:  2013-01-04       Impact factor: 3.375

3.  Equity in access to long-acting injectables in the USA.

Authors:  J Carlo Hojilla; Monica Gandhi; Derek D Satre; Mallory O Johnson; Parya Saberi
Journal:  Lancet HIV       Date:  2022-02-04       Impact factor: 12.767

4.  Self-administration of injectable contraception: a systematic review and meta-analysis.

Authors:  Caitlin E Kennedy; Ping Teresa Yeh; Mary Lyn Gaffield; Martha Brady; Manjulaa Narasimhan
Journal:  BMJ Glob Health       Date:  2019-04-02

5.  Comparing the satisfaction and efficacy of Cyclofem and contraceptive pills among females in Northern Iran: A randomized controlled trial study.

Authors:  Bita Jamali; Azade Kiapoor; Mozhgan Firoozbakht; Fatemeh Kazeminavaei; Fatemeh Taghlili
Journal:  J Adv Pharm Technol Res       Date:  2014-10

6.  Continuation of injectable contraception when self-injected vs. administered by a facility-based health worker: a nonrandomized, prospective cohort study in Uganda.

Authors:  Jane Cover; Allen Namagembe; Justine Tumusiime; Damalie Nsangi; Jeanette Lim; Dinah Nakiganda-Busiku
Journal:  Contraception       Date:  2018-04-11       Impact factor: 3.375

Review 7.  Self-administration of injectable contraceptives: a systematic review.

Authors:  C R Kim; M S Fønhus; B Ganatra
Journal:  BJOG       Date:  2016-08-23       Impact factor: 6.531

8.  Ugandan providers' views on the acceptability of contraceptive self-injection for adolescents: a qualitative study.

Authors:  Jane Cover; Allen Namagembe; Justine Tumusiime; Jeanette Lim; Carie Muntifering Cox
Journal:  Reprod Health       Date:  2018-10-03       Impact factor: 3.223

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.